Chinese Sle Treatment And Research Group

This study tests two new drugs, vunakizumab and ivarmacitinib, for people with active Takayasu's arteritis, a rare disease that causes inflammation in large blood vessels. About 180 adults aged 18-70 with active disease despite current treatments will receive these drugs along wi…

This small pilot study tests a drug called firsekibart in 15 adults with mild-to-moderate lupus who did not get better with usual therapies. The drug blocks a protein (IL-1) that causes fever and inflammation. The main goal is to see if lupus symptoms improve after 12 weeks of tr…